EligibleTrials

Using FAPI PET/MRI to Evaluate Prostate Cancer

Recruiting · NCT06675357 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Wisconsin, Madison

View the official record on ClinicalTrials.gov →
Prostate cancer

Interventions studied

FAPIMagnetic Resonance ImagingPositron Emission Tomography (PET)

What this trial is about

The goal of this clinical trial is to gain more information about how FAPI (fibroblast activation protein inhibitor) binds to certain type of cells in the tumor tissue. The main question it aims to answer is how this information can be used to better diagnose and track prostate cancer. Participants will undergo two PET/MRI scans during two research visits, each of which may last up to 2.5 hours.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.